These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38716528)

  • 1. Incidence of New-onset Hypertension and New-onset Type 2 Diabetes during or after SARS-CoV-2 Infection.
    Gupta A; Duggal R
    J Assoc Physicians India; 2023 Oct; 71(10):78-82. PubMed ID: 38716528
    [No Abstract]   [Full Text] [Related]  

  • 2. New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies.
    Rahmati M; Yon DK; Lee SW; Udeh R; McEVoy M; Kim MS; Gyasi RM; Oh H; López Sánchez GF; Jacob L; Li Y; Koyanagi A; Shin JI; Smith L
    J Med Virol; 2023 Jun; 95(6):e28833. PubMed ID: 37264687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New-Onset Diabetes Mellitus, Hypertension, Dyslipidaemia as Sequelae of COVID-19 Infection-Systematic Review.
    Wrona M; Skrypnik D
    Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk Factors for COVID-19: Diabetes, Hypertension, and Obesity.
    Buscemi S; Corleo D; Randazzo C
    Adv Exp Med Biol; 2021; 1353():115-129. PubMed ID: 35137371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis.
    Zhang T; Mei Q; Zhang Z; Walline JH; Liu Y; Zhu H; Zhang S
    BMC Med; 2022 Nov; 20(1):444. PubMed ID: 36380329
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 and diabetes mellitus: a review of the incidence, pathophysiology and management of diabetes during the pandemic.
    Faruqi J; Balasubramanyam A
    Expert Rev Endocrinol Metab; 2023 Mar; 18(2):167-179. PubMed ID: 36797835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New Onset of Diabetes Mellitus and Associated Factors among COVID-19 Patients in COVID-19 Care Centers, Addis Ababa, Ethiopia 2022.
    Sane AH; Mekonnen MS; Tsegaw MG; Zewde WC; Mesfin EG; Beyene HA; Ashine TM; Tiruneh KG; Mengistie MA
    J Diabetes Res; 2022; 2022():9652940. PubMed ID: 36420090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Fox T; Geppert J; Dinnes J; Scandrett K; Bigio J; Sulis G; Hettiarachchi D; Mathangasinghe Y; Weeratunga P; Wickramasinghe D; Bergman H; Buckley BS; Probyn K; Sguassero Y; Davenport C; Cunningham J; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Struyf T; Van den Bruel A; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Nov; 11(11):CD013652. PubMed ID: 36394900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody tests for identification of current and past infection with SARS-CoV-2.
    Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patients with prediabetes are at greater risk of developing diabetes 5 months postacute SARS-CoV-2 infection: a retrospective cohort study.
    Xu AY; Wang SH; Duong TQ
    BMJ Open Diabetes Res Care; 2023 Jun; 11(3):. PubMed ID: 37295808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cognitive dysfunction, diabetes mellitus 2 and arterial hypertension: Sequelae up to one year of COVID-19.
    Fernández-Ortega MÁ; Ponce-Rosas ER; Muñiz-Salinas DA; Rodríguez-Mendoza O; Nájera Chávez P; Sánchez-Pozos V; Dávila-Mendoza R; Barrell AE
    Travel Med Infect Dis; 2023; 52():102553. PubMed ID: 36805019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical considerations in patients with diabetes during times of COVID19: An update on lifestyle factors and antihyperglycemic drugs with focus on India.
    Gupta R; Misra A
    Diabetes Metab Syndr; 2020; 14(6):1777-1781. PubMed ID: 32942253
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New onset diabetes, type 1 diabetes and COVID-19.
    Boddu SK; Aurangabadkar G; Kuchay MS
    Diabetes Metab Syndr; 2020; 14(6):2211-2217. PubMed ID: 33395782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New-Onset Diabetes After COVID-19.
    Kim SH; Arora I; Hsia DS; Knowler WC; LeBlanc E; Mylonakis E; Pratley R; Pittas AG
    J Clin Endocrinol Metab; 2023 Oct; 108(11):e1164-e1174. PubMed ID: 37207448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global burden of new-onset hypertension associated with severe acute respiratory syndrome coronavirus 2 infection.
    Angeli F; Zappa M; Verdecchia P
    Eur J Intern Med; 2024 Jan; 119():31-33. PubMed ID: 37852842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Authors' response: Occupation and SARS-CoV-2 infection risk among workers during the first pandemic wave in Germany: potential for bias.
    Reuter M; Rigó M; Formazin M; Liebers F; Latza U; Castell S; Jöckel KH; Greiser KH; Michels KB; Krause G; Albrecht S; Öztürk I; Kuss O; Berger K; Lampl BMJ; Leitzmann M; Zeeb H; Starke KR; Schipf S; Meinke-Franze C; Ahrens W; Seidler A; Klee B; Pischon T; Andreas Deckert AD; Schmidt B; Mikolajczyk R; Karch A; Bohn B; Brenner H; Holleczek B; Dragano N
    Scand J Work Environ Health; 2022 Sep; 48(7):588-590. PubMed ID: 36153787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021.
    Barrett CE; Koyama AK; Alvarez P; Chow W; Lundeen EA; Perrine CG; Pavkov ME; Rolka DB; Wiltz JL; Bull-Otterson L; Gray S; Boehmer TK; Gundlapalli AV; Siegel DA; Kompaniyets L; Goodman AB; Mahon BE; Tauxe RV; Remley K; Saydah S
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(2):59-65. PubMed ID: 35025851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and risk of new-onset diabetes mellitus after COVID-19: a systematic review and meta-analysis.
    Bellia C; Andreadi A; D'Ippolito I; Scola L; Barraco S; Meloni M; Lauro D; Bellia A
    Front Endocrinol (Lausanne); 2023; 14():1215879. PubMed ID: 37732118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
    PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 induced Diabetes: A novel presentation.
    Chandrashekhar Joshi S; Pozzilli P
    Diabetes Res Clin Pract; 2022 Sep; 191():110034. PubMed ID: 35940303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.